Paper
Organic & Biomolecular Chemistry
1,3-Dimethyl-3-(pyridin-2-yl)indolin-2-one (2f). The reaction (cyclohexane–EtOAc–Et3N = 1 : 1 : 0.05), 37 mg (61% yield),
was carried out starting with 1f (0.5 mmol) according to the oil.
general procedure. Purified by chromatography (EtOAc), 97 mg
1H NMR (400 MHz, CDCl3): δ 7.53–7.51 (m, 2H), 7.40–7.33
(82% yield), oil. 1H NMR (400 MHz, CDCl3): δ 8.58 (d, J = (m, 5H), 7.14 (t, J = 7.5 Hz, 1H), 6.89 (d, J = 7.7 Hz, 1H),
3.9 Hz, 1H), 7.60 (td, J = 7.8, 1.8 Hz, 1H), 7.30 (dd, J = 7.7, 1.1 3.47–3.42 (m, 1H), 3.36–3.31 (m, 1H) 3.21 (s, 3H), 2.49–2.42
Hz, 1H), 7.27–7.26 (m, 2H), 7.15 (ddd, J = 7.5, 4.8, 0.9 Hz, 1H), (m, 1H), 2.30–2.23 (m, 1H), 2.13–1.99 (m, 2H). 13C NMR
7.05 (td, J = 7.5, 0.8 Hz, 1H), 6.91 (d, J = 7.8 Hz, 1H), 3.32 (s, (100 MHz, CDCl3):
δ 175.4, 174.9, 144.7, 135.3, 129.6,
3H), 1.87 (s, 3H). 13C NMR (100 MHz, CDCl3): 179.1, 159.9, 128.9, 128.7, 128.6, 128.5, 124.7, 122.6, 108.8, 66.5, 47.1,
149.7, 143.2, 136.8, 134.8, 128.2, 124.2, 122.9, 122.2, 121.0, 31.3, 27.0, 19.2. IR (neat, cm−1): 3056, 2956, 2922, 1726, 1693,
108.4, 55.1, 26.7, 23.1. IR (neat, cm−1): 3063, 2978, 2930, 1713, 1612, 1493, 1471, 1372, 1348, 1279, 757, 733, 699, 536. HRMS
1611, 1587, 1492, 1469, 1373, 1346, 1256, 1102, 1024, 751. (ESI): calcd for C19H19N2O2 ([M + H]+): 307.1441, found:
HRMS (ESI): calcd for C15H15N2O ([M + H]+): 239.1178, found: 307.1440.
239.1173.
3-(3,3-Dimethyl-2-oxopyrrolidin-1-yl)-1-methyl-3-phenylindo-
1,3-Dimethyl-3-(pyridin-3-yl)indolin-2-one (2g). The reaction lin-2-one (2m). The reaction was carried out starting with 1m
was carried out starting with 1g (0.2 mmol) according to the (0.4 mmol) according to the general procedure. Purified by
general procedure. Purified by chromatography (EtOAc), 42 mg chromatography (pentane–Et2O = 1 : 1), 44 mg (33% yield),
1
(88% yield), oil. H NMR (400 MHz, CDCl3): δ 8.51 (brs, 2H), solid, m.p. = 144–146 °C. 1H NMR (500 MHz, CDCl3):
7.73 (d, J = 7.9 Hz, 1H), 7.36 (t, J = 7.6 Hz, 1H), 7.27–7.20 δ 7.54–7.52 (m, 2H), 7.39–7.33 (m, 5H), 7.14–7.11 (m, 1H),
(m, 2H), 7.13 (t, J = 7.5 Hz, 1H), 6.95 (d, J = 7.8 Hz, 1H), 6.89–6.88 (m, 1H), 3.36–3.31 (m, 1H), 3.25–3.22 (m, 1H) 3.21
3.25 (s, 3H), 1.81 (s, 3H). 13C NMR (100 MHz, CDCl3): (s, 3H), 1.96–1.91 (m, 1H), 1.86–1.82 (m, 1H), 1.19 (s, 3H), 0.99
178.6, 148.5, 148.1, 143.3, 136.7, 134.8, 133.3, 128.8, 124.3, (s, 3H). 13C NMR (125 MHz, CDCl3): δ 180.0, 174.8, 144.6,
123.6, 123.2, 108.8, 50.7, 26.7, 23.9. IR (neat, cm−1): 3037, 135.1, 129.6, 128.9, 128.62, 128.59, 124.3, 122.6, 108.8, 66.5,
2924, 1711, 1611, 1493, 1470, 1371, 1343, 1097, 1021, 713. 43.6, 40.7, 34.8, 26.9, 24.5, 23.6. IR (neat, cm−1): 3068,
HRMS (ESI): calcd for C15H15N2O ([M + H]+): 239.1178, found: 2962, 2926, 2873, 1719, 1696, 1613, 1492, 1468, 1398, 1367,
239.1178.
1342, 1275, 1257, 1127, 936, 738, 701, 621, 522, 511. HRMS
1,3-Dimethyl-3-(pyridin-4-yl)indolin-2-one (2h). The reac- (ESI): calcd for C21H23N2O2 ([M + H]+): 335.1754, found:
tion was carried out starting with 1h (0.5 mmol) according to 335.1751.
the general procedure. Purified by chromatography (EtOAc),
3-(3,3-Dimethyl-2-oxopiperidin-1-yl)-1-methyl-3-phenylindo-
104 mg (88% yield), oil. 1H NMR (400 MHz, CDCl3): δ 8.53 lin-2-one (2n). The reaction was carried out starting with 1n
(brs, 2H), 7.37 (td, J = 7.6, 1.3 Hz, 1H), 7.24 (d, J = 5.3 Hz, 2H), (0.4 mmol) according to the general procedure. Purified by
7.19 (dd, J = 7.3, 1.0 Hz, 1H), 7.13 (td, J = 7.5, 0.7 Hz, 1H), 6.95 chromatography (pentane–Et2O = 1 : 1), 41 mg (30% yield),
(d, J = 7.8 Hz, 1H), 3.25 (s, 3H), 1.78 (s, 3H). 13C NMR semi-solid. H NMR (500 MHz, CDCl3): δ 7.85–7.44 (brm, 1H),
1
(100 MHz, CDCl3): 178.1, 150.1, 149.8, 143.3, 133.1, 128.8, 7.37–7.30 (m, 6H), 7.10 (td, J = 7.6, 0.9 Hz, 1H), 6.86 (d, J =
124.3, 123.2, 122.0, 108.8, 51.9, 26.7, 23.5. IR (neat, cm−1): 7.8 Hz, 1H), 3.34–3.29 (m, 1H), 3.18 (s, 3H), 3.17–3.13 (m, 1H),
3051, 2978, 2930, 1708, 1611, 1595, 1492, 1470, 1373, 1347, 1.92–1.85 (m, 1H), 1.80–1.67 (m, 3H), 1.30 (s, 3H), 1.07 (s, 3H).
1024, 754. HRMS (ESI): calcd for C15H15N2O ([M + H]+): 13C NMR (125 MHz, CDCl3): δ 177.3, 175.3, 144.5, 135.8, 129.2,
239.1178, found: 239.1170.
129.1, 128.8, 128.6, 123.5, 122.2, 108.6, 69.3, 48.7, 39.6, 36.6,
1,3-Dimethyl-3-(quinolin-2-yl)indolin-2-one (2i). The reac- 28.4, 27.2, 26.9, 21.1. IR (neat, cm−1): 3060, 2936, 2866, 1720,
tion was carried out starting with 1i (0.2 mmol) according to 1641, 1610, 1492, 1469, 1316, 1171, 1128, 726, 695, 613, 505,
the general procedure. Purified by chromatography (cyclo- 489. HRMS (ESI): calcd for C22H25N2O2 ([M + H]+): 349.1910,
hexane–EtOAc = 1 : 1), 51 mg (89% yield), solid, m.p. = found: 349.1911.
1
131–133 °C. H NMR (500 MHz, CDCl3): δ 8.13 (d, J = 8.5 Hz,
1H), 8.01 (d, J = 8.6 Hz, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.70 (td,
Computational details
J = 6.9, 1.4 Hz, 1H), 7.52–7.49 (m, 1H), 7.34 (d, J = 6.8 Hz, 1H), Density functional [UB3LYP/LANL2DZ on Cu and Cl,40 6-31G-
7.31 (dd, J = 7.7, 1.2 Hz, 1H), 7.20 (d, J = 8.6 Hz, 1H), 7.06 (td, (d,p) on other atoms] calculations were used to examine
J = 7.6, 0.9 Hz, 1H), 6.95 (d, J = 7.8 Hz, 1H), 3.36 (s, 3H), important segments of the potential energy surface for the
2.01 (s, 3H). 13C NMR (125 MHz, CDCl3): 179.1, 159.2, CuCl2 mediated oxidative coupling. Single point PCM calcu-
147.9, 143.2, 136.8, 134.7, 129.9, 129.4, 128.3, 127.4, 127.3, lations in DMF and toluene of all the gas phase optimized
41
126.5, 124.6, 123.0, 119.2, 108.3, 55.8, 26.7, 23.1. IR (neat, structures yielded the solvent corrected energy Esolv
.
The
cm−1): 3059, 2995, 2938, 1701, 1609, 1600, 1492, 1470, 1443, united atom topological model with UAHF radii was used. For
1424, 1349, 1300, 1258, 1118, 1098, 1023, 813, 757, 695. the PCM calculations, the same level of theory as in the gas
HRMS (ESI): calcd for C19H17N2O ([M + H]+): 289.1335, found: phase calculations was used. Gas phase Gibbs free energy cor-
289.1333.
rections Gcorr (P = 1 atm, T = 298 K) were considered for each
1-Methyl-3-(2-oxopyrrolidin-1-yl)-3-phenylindolin-2-one (2l). species and the total Gibbs free energy G of each optimized
The reaction was carried out starting with 1l (0.2 mmol) structure was taken as G = Esolv + Gcorr. The calculations were
according to the general procedure. Purified by chromatography performed with the Gaussian09 package.42
6742 | Org. Biomol. Chem., 2013, 11, 6734–6743
This journal is © The Royal Society of Chemistry 2013